Exodus Point Capital Management, LP Biom X Inc. Transaction History

Exodus Point Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$47.1 - $78.0 $808,283 - $1.34 Million	-17,161 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$61.2 - $104.4 $417,200 - $711,694	-6,817 Reduced 28.43%	17,161 $120,000
Q4 2019 Feb 14, 2020	BUY	$61.3 - $108.0 $1.47 Million - $2.59 Million	23,978 New	23,978 $232,000

301K

Ticker PHGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,982,300
Market Cap $19.5M
Description
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.